FDA Adverse Event Injury Summary report: N

ACCU-CHEK TENDERLINK

MDR report key: 3181261 · Received June 21, 2013

Report

Report Number
2183996-2013-01133
Event Type
Injury
Date Received
June 21, 2013
Date of Event
June 9, 2013
Report Date
September 11, 2013
Manufacturer
UNOMEDICAL A/S
Product Code
FPA
PMA / PMN Number
NA
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AR
Reporter Occupation
MEDICAL EQUIPMENT COMPANY TECHNICIAN/REPRESENTATIVE

Narratives

Additional Manufacturer Narrative · 1

THE INCIDENT OCCURRED OUTSIDE THE UNITED STATES. INFORMATION CONTAINED WITHIN THIS REPORT IS ALL THAT IS AVAILABLE AT THIS TIME. IF FURTHER INFORMATION IS OBTAINED, IT WILL BE PROVIDED IN THE SUPPLEMENTAL REPORT. NO PRODUCT REQUESTED TO BE RETURNED.

Additional Manufacturer Narrative · 1

NO SAMPLES WERE RETURNED FOR INVESTIGATION HOWEVER THE REFERENCE SAMPLES WERE VISUALLY INSPECTED AND TESTED FOR FLOW AND LEAK. ALL TEST RESULTS WERE WITHIN SPECIFICATIONS. NO PRODUCT WAS RETURNED.

Description of Event or Problem · 1

ON (B)(6) 2013, IT WAS REPORTED THAT THE PATIENT WAS USING AN INFUSION SITE ON HER ARM. HER BLOOD GLUCOSE LEVEL BECOME ELEVATED AND CHANGED THE SITE TO HER ABDOMEN. THE PATIENT ATTEMPTED TO BOLUS, BUT HER BLOOD GLUCOSE LEVEL CONTINUED TO RISE. SHE WENT TO THE HOSPITAL AND HER BLOOD GLUCOSE LEVEL WAS AROUND 600 MG/DL AND SHE HAD MILD KETOSIS. THE INFUSION DEVICE WAS CHECKED AND FUNCTIONS AS INTENDED. THE PATIENT'S DOCTOR THINKS, THAT DUE TO THE PATIENT BEING OBESE, THE INSULIN ENTERS THE BODY BUT IS TRAPPED IN THE ADIPOSE TISSUE. NO PRODUCT WAS REQUESTED TO BE RETURNED FOR PRODUCT EVALUATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
282277 ACCU-CHEK TENDERLINK INSULIN INFUSION SET FPA UNOMEDICAL A/S 00700006954 227633

Patients

Seq Age Sex Outcome Treatment
1 060 YR Hospitalization